Oak Ridge Investments’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $6.4M | Buy |
91,644
+912
| +1% | +$63.7K | 0.46% | 44 |
|
2025
Q1 | $6.67M | Sell |
90,732
-53,241
| -37% | -$3.91M | 0.55% | 39 |
|
2024
Q4 | $9.43M | Buy |
143,973
+7,341
| +5% | +$481K | 0.74% | 29 |
|
2024
Q3 | $10.6M | Buy |
136,632
+9,141
| +7% | +$712K | 0.93% | 23 |
|
2024
Q2 | $9.94M | Buy |
127,491
+5,887
| +5% | +$459K | 0.95% | 21 |
|
2024
Q1 | $8.24M | Buy |
121,604
+5,286
| +5% | +$358K | 0.83% | 28 |
|
2023
Q4 | $7.83M | Buy |
116,318
+927
| +0.8% | +$62.4K | 0.9% | 23 |
|
2023
Q3 | $7.81M | Buy |
115,391
+2,647
| +2% | +$179K | 1% | 23 |
|
2023
Q2 | $8.07M | Sell |
112,744
-856
| -0.8% | -$61.3K | 1% | 20 |
|
2023
Q1 | $7.88M | Sell |
113,600
-646
| -0.6% | -$44.8K | 1.07% | 15 |
|
2022
Q4 | $7.75M | Buy |
114,246
+39
| +0% | +$2.64K | 1.15% | 16 |
|
2022
Q3 | $6.26M | Buy |
114,207
+6,396
| +6% | +$351K | 0.95% | 21 |
|
2022
Q2 | $7.12M | Buy |
107,811
+47,758
| +80% | +$3.16M | 1.04% | 17 |
|
2022
Q1 | $3.98M | Sell |
60,053
-7,326
| -11% | -$486K | 0.44% | 70 |
|
2021
Q4 | $3.92M | Buy |
67,379
+8,735
| +15% | +$509K | 0.33% | 90 |
|
2021
Q3 | $3.52M | Buy |
+58,644
| New | +$3.52M | 0.31% | 101 |
|